Status:
COMPLETED
Measuring Adherence to Control Hypertension
Lead Sponsor:
Columbia University
Collaborating Sponsors:
National Heart, Lung, and Blood Institute (NHLBI)
Conditions:
Hypertension
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
The purpose of this study is to test whether accurately measuring patients' adherence to their blood pressure medications with electronic pillbox monitors and then providing clinicians with this infor...
Detailed Description
Despite the presence of numerous effective medications, one-half of the adults receiving treatment for hypertension in the United States have uncontrolled blood pressure. At least one-third of these h...
Eligibility Criteria
Inclusion
- Inclusion criteria
- established diagnosis of hypertension
- prescribed at least one blood pressure (BP) medication
- at least two consecutive clinic visits with elevated BP according to Joint National Committee (JNC-7) guidelines (i.e., BP ≥ 140/90 mmHg or ≥ 130/80 mmHg if diabetes or chronic kidney disease)
- 18 to 80 years old
- at least one prior visit with a clinician enrolled in the study
- Exclusion criteria
- severe mental illness
- resided in a long-term care facility
- unable to use the electronic adherence device due to physical or cognitive impairment
- non-English or non-Spanish speaking
- unavailable for follow-up
Exclusion
Key Trial Info
Start Date :
January 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2014
Estimated Enrollment :
124 Patients enrolled
Trial Details
Trial ID
NCT01257347
Start Date
January 1 2011
End Date
July 1 2014
Last Update
April 5 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Columbia University Medical Center
New York, New York, United States, 10032